Analyst Ratings for Cyclacel Pharmaceuticals (CYCC)

CYCC Rating Summary

  |   Expand Research on CYCC
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5.7 / 10   Percentile Rank: 60%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/23/2024 Roth/MKM Jonathan Aschoff Downgrade Neutral
(Buy)		 1.00
(11.00)		 1.43
(6.37)		 345.45% Details
12/19/2023 Brookline Capital Markets Kumaraguru Raja Downgrade Hold
(Buy)		 N/A
(N/A)		 3.69
(6.37)		 72.63% Details